# Glaukos Corporation (GKOS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GKOS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 336.18M | $ -38.16M | $ -4.40M | $ 102.84M | $ 682.49M |
| 2025 | $ 519.58M | $ -192.18M | $ -22.99M | $ 139.64M | $ 656.16M |
| 2024 | $ 403.07M | $ -153.85M | $ -71.07M | $ 103.40M | $ 766.93M |
| 2023 | $ 340.28M | $ -145.60M | $ -84.34M | $ 385.05M | $ 461.77M |
| 2022 | $ 315.99M | $ -110.81M | $ -70.77M | $ 382.91M | $ 530.01M |
| 2021 | $ 349.48M | $ -58.95M | $ -27.43M | $ 383.39M | $ 587.15M |
| 2020 | $ 286.58M | $ -153.31M | $ -38.12M | $ 270.81M | $ 667.45M |
| 2019 | $ 305.89M | $ 19.91M | $ -6.57M | $ 75.03M | $ 673.27M |
| 2018 | $ 239.41M | $ -17.10M | $ 11.29M | $ 0 | $ 173.86M |
| 2017 | $ 214.54M | $ -123.9K | $ 25.86M | $ 0 | $ 138.20M |
| 2016 | $ 157.39M | $ 6.22M | $ 8.30M | $ 0 | $ 117.27M |
| 2015 | $ 100.67M | $ -52.29M | $ -4.30M | $ 9.70M | $ 95.19M |
| 2014 | $ 64.41M | $ -17.13M | $ -11.27M | $ 19.35M | $ -151.30M |
| 2013 | $ 29.79M | $ -17.98M | $ -20.13M | $ 17.50M | $ 15.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.15 |
| Liabilities / Eq | 0.35 |
| Current Ratio | 5.04 |

## Other views

- [Metrics](https://sponda.capital/en/GKOS.md)
- [Charts](https://sponda.capital/en/GKOS/charts.md)
- [Compare](https://sponda.capital/en/GKOS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.